Picture of Hansoh Pharmaceutical logo

3692 Hansoh Pharmaceutical Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Annual cashflow statement for Hansoh Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line3,0013,0983,3002,948
Depreciation
Amortisation
Non-Cash Items-164-135-25478
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital291-806-748-630
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities3,3302,3902,5772,741
Capital Expenditures-592-1,428-460-273
Purchase of Fixed Assets
Other Investing Cash Flow Items-6,483-1,446-1,799-5,662
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-7,076-2,874-2,259-5,935
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7,993-1,0363,417-818
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4,380-2,2823,655-4,053